AAAAAA

   
Results: 1-14 |
Results: 14
LACK OF EFFICACY OF LOW-DOSE ORAL INTERFERON-ALPHA IN SYMPTOMATIC HIV-1 INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: KATABIRA ET SEWANKAMBO NK MUGERWA RD BELSEY EM MUBIRU FX OTHIENO C KATAAHA P KARAM M YOULE M PERRIENS JH LANGE JMA
Citation: Et. Katabira et al., LACK OF EFFICACY OF LOW-DOSE ORAL INTERFERON-ALPHA IN SYMPTOMATIC HIV-1 INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, SEXUALLY TRANSMITTED INFECTIONS, 74(4), 1998, pp. 265-270
IMPACT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ON THE INITIAL BACTERIOLOGICAL AND RADIOGRAPHIC MANIFESTATIONS OF PULMONARY TUBERCULOSIS IN UGANDA
Authors: JOHNSON JL VJECHA MJ OKWERA A HATANGA E BYEKWASO F WOLSKI K AISU T WHALEN CC HUEBNER R MUGERWA RD ELLNER JJ
Citation: Jl. Johnson et al., IMPACT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ON THE INITIAL BACTERIOLOGICAL AND RADIOGRAPHIC MANIFESTATIONS OF PULMONARY TUBERCULOSIS IN UGANDA, The international journal of tuberculosis and lung disease, 2(5), 1998, pp. 397-404
QUESTIONS ABOUT A PLACEBO-CONTROLLED TRIAL OF PREVENTIVE THERAPY FOR TUBERCULOSIS IN HIV-INFECTED UGANDANS - REPLY
Authors: WHALEN CC JOHNSON JL MUGERWA RD ELLNER JJ
Citation: Cc. Whalen et al., QUESTIONS ABOUT A PLACEBO-CONTROLLED TRIAL OF PREVENTIVE THERAPY FOR TUBERCULOSIS IN HIV-INFECTED UGANDANS - REPLY, The New England journal of medicine, 338(12), 1998, pp. 842-842
INDUCTION OF THE ANTIGEN-85 COMPLEX OF MYCOBACTERIUM-TUBERCULOSIS IN SPUTUM - A DETERMINANT OF OUTCOME IN PULMONARY TUBERCULOSIS TREATMENT
Authors: WALLIS RS PERKINS M PHILLIPS M JOLOBA M DEMCHUK B NAMALE A JOHNSON JL WILLIAMS D WOLSKI K TEIXEIRA L DIETZE R MUGERWA RD EISENACH K ELLNER JJ
Citation: Rs. Wallis et al., INDUCTION OF THE ANTIGEN-85 COMPLEX OF MYCOBACTERIUM-TUBERCULOSIS IN SPUTUM - A DETERMINANT OF OUTCOME IN PULMONARY TUBERCULOSIS TREATMENT, The Journal of infectious diseases, 178(4), 1998, pp. 1115-1121
HIV-1 RISK AND VACCINE ACCEPTABILITY IN THE UGANDAN MILITARY
Authors: HOM DL JOHNSON JL MUGYENYI P BYARUHANGA R KITYO C LOUGLIN A SVILAR GM VJECHA M MUGERWA RD ELLNER JJ
Citation: Dl. Hom et al., HIV-1 RISK AND VACCINE ACCEPTABILITY IN THE UGANDAN MILITARY, Journal of acquired immune deficiency syndromes and human retrovirology, 15(5), 1997, pp. 375-380
2-STEP TUBERCULIN SKIN TESTING IN HIV-INFECTED PERSONS IN UGANDA
Authors: HECKER MT JOHNSON JL WHALEN CC NYOLE S MUGERWA RD ELLNER JJ
Citation: Mt. Hecker et al., 2-STEP TUBERCULIN SKIN TESTING IN HIV-INFECTED PERSONS IN UGANDA, American journal of respiratory and critical care medicine, 155(1), 1997, pp. 81-86
RISK-FACTORS FOR ADVERSE DRUG-REACTIONS DURING THIACETAZONE TREATMENTOF PULMONARY TUBERCULOSIS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED ADULTS
Authors: OKWERA A JOHNSON JL VJECHA MJ WOLSKI K WHALEN CC HOM D HUEBNER R MUGERWA RD ELLNER JJ
Citation: A. Okwera et al., RISK-FACTORS FOR ADVERSE DRUG-REACTIONS DURING THIACETAZONE TREATMENTOF PULMONARY TUBERCULOSIS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED ADULTS, The international journal of tuberculosis and lung disease, 1(5), 1997, pp. 441-445
RISK-FACTORS FOR RELAPSE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED ADULTS WITH PULMONARY TUBERCULOSIS
Authors: JOHNSON JL OKWERA A VJECHA MJ BYEKWASO F NAKIBALI J NYOLE S MILBERG J AISU T WHALEN CC MUGERWA RD ELLNER JJ
Citation: Jl. Johnson et al., RISK-FACTORS FOR RELAPSE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED ADULTS WITH PULMONARY TUBERCULOSIS, The international journal of tuberculosis and lung disease, 1(5), 1997, pp. 446-453
A TRIAL OF 3 REGIMENS TO PREVENT TUBERCULOSIS IN UGANDAN ADULTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: WHALEN CC JOHNSON JL OKWERA A HOM DL HUEBNER R MOGYENYI P MUGERWA RD ELLNER JJ
Citation: Cc. Whalen et al., A TRIAL OF 3 REGIMENS TO PREVENT TUBERCULOSIS IN UGANDAN ADULTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, The New England journal of medicine, 337(12), 1997, pp. 801-808
IMMUNE ACTIVATION, ALLERGIC DRUG TOXICITY AND MORTALITY IN HIV-POSITIVE TUBERCULOSIS
Authors: WALLIS RS HELFAND MS WHALEN CC JOHNSON JL MUGERWA RD VJECHA M OKWERA A ELLNER JJ
Citation: Rs. Wallis et al., IMMUNE ACTIVATION, ALLERGIC DRUG TOXICITY AND MORTALITY IN HIV-POSITIVE TUBERCULOSIS, Tubercle and lung disease, 77(6), 1996, pp. 516-523
PENTOXIFYLLINE THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PERSONS WITH TUBERCULOSIS - A RANDOMIZED, CONTROLLED TRIAL
Authors: WALLIS RS NSUBUGA P WHALEN C MUGERWA RD OKWERA A OETTE D JACKSON JB JOHNSON JL ELLNER JJ
Citation: Rs. Wallis et al., PENTOXIFYLLINE THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PERSONS WITH TUBERCULOSIS - A RANDOMIZED, CONTROLLED TRIAL, The Journal of infectious diseases, 174(4), 1996, pp. 727-733
HUMAN-IMMUNODEFICIENCY-VIRUS AND AIDS IN UGANDA
Authors: MUGERWA RD MARUM LH SERWADDA D
Citation: Rd. Mugerwa et al., HUMAN-IMMUNODEFICIENCY-VIRUS AND AIDS IN UGANDA, East African medical journal, 73(1), 1996, pp. 20-26
REDUCED SENSITIVITY OF TUBERCULOSIS SERODIAGNOSIS IN PATIENTS WITH AIDS IN UGANDA
Authors: DANIEL TM SIPPOLA AA OKWERA A KABENGERA S HATANGA E AISU T NYOLE S BYEKWASO F VJECHA M FERGUSON LE KATAAHA P MUGERWA RD
Citation: Tm. Daniel et al., REDUCED SENSITIVITY OF TUBERCULOSIS SERODIAGNOSIS IN PATIENTS WITH AIDS IN UGANDA, Tubercle and lung disease, 75(1), 1994, pp. 33-37
CONCEPTS, MISCONCEPTIONS, FEARS AND EXPECTATIONS FROM HIV-RELATED DRUG TRIALS IN UGANDA - LESSONS FOR FUTURE VACCINE TRIALS
Authors: MUGERWA RD ELLNER JJ SERWADDA D
Citation: Rd. Mugerwa et al., CONCEPTS, MISCONCEPTIONS, FEARS AND EXPECTATIONS FROM HIV-RELATED DRUG TRIALS IN UGANDA - LESSONS FOR FUTURE VACCINE TRIALS, AIDS research and human retroviruses, 10, 1994, pp. 190000251-190000251
Risultati: 1-14 |